These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 32612571)
1. Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation. Khalilidehkordi E; Clarke L; Arnett S; Bukhari W; Jimenez Sanchez S; O'Gorman C; Sun J; Prain KM; Woodhall M; Silvestrini R; Bundell CS; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brown M; Brownlee W; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Fabis-Pedrini MJ; Fulcher D; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Kilpatrick TJ; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonell RAL; Mason DF; McCombe PA; Pereira J; Pollard JD; Ramanathan S; Reddel SW; Shaw C; Spies J; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AG; Marriott MP; Parratt J; Slee M; Taylor BV; Willoughby E; Brilot F; Vincent A; Waters P; Broadley SA Front Neurol; 2020; 11():537. PubMed ID: 32612571 [TBL] [Abstract][Full Text] [Related]
2. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B; J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206 [TBL] [Abstract][Full Text] [Related]
3. Neuromyelitis Optica Spectrum Disorder: Clinical Burden and Cost of Relapses and Disease-Related Care in US Clinical Practice. Royston M; Kielhorn A; Weycker D; Shaff M; Houde L; Tanvir I; Bhattacharyya S; Levy M Neurol Ther; 2021 Dec; 10(2):767-783. PubMed ID: 34046846 [TBL] [Abstract][Full Text] [Related]
5. Multicentric clinical and epidemiological comparison of neuromyelitis optica spectrum disorder with multiple sclerosis from India. Gupta S; Rehani V; Acharya R; Purohit P; Anadure R; Ahmad F; Soni R; Gupta A; Hiremath R Mult Scler Relat Disord; 2021 Jan; 47():102616. PubMed ID: 33166808 [TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of neuromyelitis optica spectrum disorders in childhood]. Zhou J; Zhang Y; Ji TY; Jin YW; Bao XH; Zhang YH; Xiong H; Chang XZ; Jiang YW; Wu Y Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):118-124. PubMed ID: 30695886 [No Abstract] [Full Text] [Related]
7. Different Phenotypes at Onset in Neuromyelitis Optica Spectrum Disorder Patients with Aquaporin-4 Autoimmunity. Long Y; Liang J; Wu L; Lin S; Gao C; Chen X; Qiu W; Yang Y; Zheng X; Yang N; Gao M; Chen Y; Wang Z; Su Q Front Neurol; 2017; 8():62. PubMed ID: 28293214 [TBL] [Abstract][Full Text] [Related]
9. Short transverse myelitis in Chinese patients with neuromyelitis optica spectrum disorders. Hu H; You X; Ye J Mult Scler Relat Disord; 2018 Apr; 21():78-83. PubMed ID: 29499441 [TBL] [Abstract][Full Text] [Related]
10. A prospective case-control study comparing optical coherence tomography characteristics in neuromyelitis optica spectrum disorder- optic neuritis and idiopathic optic neuritis. Zhao X; Qiu W; Zhang Y; Luo Y; Zhang X; Lu L; Yang H BMC Ophthalmol; 2018 Sep; 18(1):247. PubMed ID: 30217177 [TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders]. Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501 [TBL] [Abstract][Full Text] [Related]
13. Patterns of neuromyelitis optica spectrum disorder attacks in different age groups and sexes depending on the status of immunosuppressive therapy: A retrospective cohort study. Luo W; Shi Z; Kong L; Wang X; Zhou H Eur J Neurol; 2024 Mar; 31(3):e16178. PubMed ID: 38117536 [TBL] [Abstract][Full Text] [Related]
15. Relapses shortly after rituximab treatment in neuromyelitis optica spectrum disorder. Shi B; Zhao M; Qiao L; Huang F; Zhou S; Wei Y; Wang J; Wang N Mult Scler Relat Disord; 2021 Sep; 54():103143. PubMed ID: 34273608 [TBL] [Abstract][Full Text] [Related]
16. [Progress in the treatment of neuromyelitis optica spectrum disorders related optic neuritis]. Song HL; Xu QG; Wei SH Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):539-543. PubMed ID: 32842338 [TBL] [Abstract][Full Text] [Related]
17. Seasonal variation in attacks of neuromyelitis optica spectrum disorders and multiple sclerosis: Evaluation of 794 attacks from a nationwide registry in Argentina. Carnero Contentti E; Lopez PA; Pettinicchi JP; Criniti J; Pappolla A; Miguez J; Patrucco L; Cristiano E; Liwacki S; Tkachuk V; Balbuena ME; Vrech C; Deri N; Correale J; Marrodan M; Ysrraelit MC; Leguizamon F; Luetic G; Menichini ML; Tavolini D; Mainella C; Zanga G; Burgos M; Hryb J; Barboza A; Lazaro L; Alonso R; Fernández Liguori N; Nadur D; Chercoff A; Alonso Serena M; Caride A; Paul F; Rojas JI Mult Scler Relat Disord; 2022 Feb; 58():103466. PubMed ID: 34929456 [TBL] [Abstract][Full Text] [Related]
18. Differences in clinical features between optic neuritis in neuromyelitis optica spectrum disorders and in multiple sclerosis. Srikajon J; Siritho S; Ngamsombat C; Prayoonwiwat N; Chirapapaisan N; Mult Scler J Exp Transl Clin; 2018; 4(3):2055217318791196. PubMed ID: 30116549 [TBL] [Abstract][Full Text] [Related]
19. Enhancing Brain Lesions during Acute Optic Neuritis and/or Longitudinally Extensive Transverse Myelitis May Portend a Higher Relapse Rate in Neuromyelitis Optica Spectrum Disorders. Orman G; Wang KY; Pekcevik Y; Thompson CB; Mealy M; Levy M; Izbudak I AJNR Am J Neuroradiol; 2017 May; 38(5):949-953. PubMed ID: 28302609 [TBL] [Abstract][Full Text] [Related]
20. The clinical profile of NMOSD in Australia and New Zealand. Bukhari W; Clarke L; O'Gorman C; Khalilidehkordi E; Arnett S; Prain KM; Woodhall M; Silvestrini R; Bundell CS; Ramanathan S; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brownlee W; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Dear K; Fabis-Pedrini MJ; Fulcher D; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Jimenez-Sanchez S; Kilpatrick TJ; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonnell RAL; Mason DF; McCombe PA; Pereira J; Pollard JD; Reddel SW; Shaw C; Spies J; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AG; Marriott MP; Parratt J; Slee M; Taylor BV; Willoughby E; Wilson RJ; Brilot F; Vincent A; Waters P; Broadley SA J Neurol; 2020 May; 267(5):1431-1443. PubMed ID: 32006158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]